Impact of monoclonal anti-CD38 antibody on collected myeloid and erythroid progenitor cells and clinical course of autologous stem cell transplant for patients with multiple myeloma

被引：0
|
作者：
Manjappa, Shivaprasad [1 ]
Eduafo, Augusta [2 ]
Fox, Robert [1 ]
Reese, Jane [1 ]
Schmikla, Hannah [1 ]
Kolk, Merle [1 ]
Driscoll, James [1 ]
Malek, Ehsan [3 ]
机构：
[1] Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA
[2] St Johns Med Ctr, Westlake, OH USA
[3] Case Western Reserve Univ, Cleveland, OH 44106 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2022年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-026
引用
收藏
页码：S50 / S50
页数：1
相关论文
共 50 条
  • [21] Considerations for pre-transfusion immunohaematology testing in patients receiving the anti-CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma
    Quach, Hang
    Benson, Simon
    Haysom, Helen
    Wilkes, Anne-Marie
    Zacher, Nicole
    Cole-Sinclair, Merrole
    Prince, Henry Miles
    Mollee, Peter
    Spencer, Andrew
    Ho, Phoebe Joy
    Harrison, Simon J.
    Lee, Cindy
    Augustson, Bradley
    Daly, James
    INTERNAL MEDICINE JOURNAL, 2018, 48 (02) : 210 - 220
  • [22] Hepatitis B reactivation in patients with multiple myeloma treated with anti-CD38 monoclonal antibody-based therapies: a pharmacovigilance analysis
    Moore, Donald C. C.
    Elmes, Joseph B. B.
    Arnall, Justin R. R.
    Strassels, Scott A. A.
    Patel, Jai N. N.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2023, 45 (06) : 1492 - 1495
  • [23] Failure of mobilization of hematopoietic stem cells associated with elevated serum levels of anti-CD38 monoclonal antibody
    Seth, Abhishek
    Murray, David
    Buadi, Francis K.
    Gertz, Morie A.
    Yadav, Udit
    Kumar, Shaji K.
    Gonsalves, Wilson I.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (02) : 318 - 321
  • [24] Pre-Clinical Efficacy of the Anti-CD38 Monoclonal Antibody (mAb) Isatuximab in Acute Myeloid Leukemia (AML)
    Jelinek, Tomas
    Zabaleta, Aintzane
    Perez, Cristina
    Ajona, Daniel
    Alignani, Diego
    Rodriguez, Idoia
    Garate, Sonia
    Sarvide, Sarai
    Lasa, Marta
    Maiso, Patricia
    Prosper, Felipe
    Hajek, Roman
    San Miguel, Jesus F.
    Paiva, Bruno
    BLOOD, 2017, 130
  • [25] Daratumumab, a Novel Potent Human Anti-CD38 Monoclonal Antibody, Induces Significant Killing of Human Multiple Myeloma Cells: Therapeutic Implication
    Tai, Yu-Tzu
    de Weers, Michel
    Li, Xian-Feng
    Song, Weihua
    Nahar, Sabikun
    Bakker, Joost M.
    Vink, Tom
    Jacobs, Danielle
    Oomen, Lukas
    Bleeker, Wim K.
    Munshi, Nikhil C.
    van de Winkel, Jan G. J.
    Parren, Paul W. H. I.
    Richardson, Paul
    Anderson, Kenneth C.
    BLOOD, 2009, 114 (22) : 252 - 252
  • [26] Selection, Expansion, and Unique Pretreatment of Allogeneic Human Natural Killer Cells with Anti-CD38 Monoclonal Antibody for Efficient Multiple Myeloma Treatment
    Motais, Benjamin
    Charvatova, Sandra
    Walek, Zuzana
    Hrdinka, Matous
    Smolarczyk, Ryszard
    Cichon, Tomasz
    Czapla, Justyna
    Giebel, Sebastian
    Simicek, Michal
    Jelinek, Tomas
    Sevcikova, Tereza
    Sobotka, Jiri
    Koristek, Zdenek
    Hajek, Roman
    Bago, Juli R.
    CELLS, 2021, 10 (05)
  • [27] Selinexor containing regimens in patients with multiple myeloma (MM) previously treated with anti-CD38 monoclonal antibodies (αCD38 mAbs).
    Gasparetto, Cristina
    Lipe, Brea
    Tuchman, Sascha
    Bahlis, Nizar J.
    Sutherland, Heather J.
    Rossi, Adriana C.
    Lentzsch, Suzanne
    Baljevic, Muhamed
    Callander, Natalie Scott
    Venner, Christopher P.
    Sebag, Michael
    White, Darrell
    Kotb, Rami
    Chen, Christine
    Biran, Noa
    Madan, Sumit
    LeBlanc, Richard
    DeCastro, Andrew
    Schiller, Gary J.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [28] Survival and drug treatment patterns in multiple myeloma patients exposed to an anti-CD38 monoclonal antibody, a proteasome inhibitor and an immunomodulatory imide drugs
    Hoveling, Liza
    de Jong, Hilda J.
    Penning-van Beest, Fernie J.
    Holthuis, Emily
    Smits, Elisabeth
    Dalhuisen, Sander
    Dinkla, Sip
    Herings, Ron M. C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 313 - 314
  • [29] Evolution of frontline treatment for multiple myeloma: clinical investigation of quadruplets containing carfilzomib and anti-CD38 monoclonal antibodies
    Costa, Luciano J.
    Gay, Francesca
    Landgren, Ola
    Mateos, Maria-Victoria
    Moreau, Philippe
    Touzeau, Cyrille
    Ertel, Franziska
    Mcfadden, Ian
    Najdi, Rani
    Weisel, Katja
    ANNALS OF HEMATOLOGY, 2025, : 1329 - 1351
  • [30] MECHANISM OF ACTION (MOA) OF THE ANTI-CD38 MONOCLONAL ANTIBODY ISATUXIMAB IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)
    Zabaleta, Aintzane
    Jelinek, Tomas
    Simoes, Catia
    Perez, Cristina
    Prosper, Felipe
    Martinez-Cuadron, D.
    Bergua, J. M.
    Vives, S.
    Algarra, L.
    Tormo, M.
    Martinez, P.
    Serrano, J.
    Herrera, P.
    Ramos, F.
    Salamero, O.
    Lavilla, E.
    Sanz, M. A.
    Montesinos, P.
    San Miguel, J. F.
    Paiva, Bruno
    HAEMATOLOGICA, 2020, 105 : 60 - 60
12345